<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Effects of hypothalamic leptin gene therapy on osteopetrosis in leptin-deficient mice</title>
				<funder ref="#_2q4SAre">
					<orgName type="full">USDA</orgName>
				</funder>
				<funder ref="#_b9MJhhw">
					<orgName type="full">NASA</orgName>
				</funder>
				<funder ref="#_KCugWpY">
					<orgName type="full">National Institutes of Health</orgName>
					<orgName type="abbreviated">NIH</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher>Bioscientifica</publisher>
				<availability  status="unknown">
					<licence/>
				</availability>
				<date type="published" when="2019-02-01">2019 February 01.</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Kenneth</forename><forename type="middle">A</forename><surname>Philbrick</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">School of Biological and Population Health Sciences</orgName>
								<orgName type="laboratory">Skeletal Biology Laboratory</orgName>
								<orgName type="institution">Oregon State University</orgName>
								<address>
									<postCode>97331</postCode>
									<settlement>Corvallis</settlement>
									<region>OR</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Stephen</forename><forename type="middle">A</forename><surname>Martin</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">School of Biological and Population Health Sciences</orgName>
								<orgName type="laboratory">Skeletal Biology Laboratory</orgName>
								<orgName type="institution">Oregon State University</orgName>
								<address>
									<postCode>97331</postCode>
									<settlement>Corvallis</settlement>
									<region>OR</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>BS</roleName><forename type="first">Amy</forename><forename type="middle">R</forename><surname>Colagiovanni</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">School of Biological and Population Health Sciences</orgName>
								<orgName type="laboratory">Skeletal Biology Laboratory</orgName>
								<orgName type="institution">Oregon State University</orgName>
								<address>
									<postCode>97331</postCode>
									<settlement>Corvallis</settlement>
									<region>OR</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Adam</forename><forename type="middle">J</forename><surname>Branscum</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Biostatistics Program</orgName>
								<orgName type="department" key="dep2">School of Biological and Population Health Sciences</orgName>
								<orgName type="institution">Oregon State University</orgName>
								<address>
									<postCode>97331</postCode>
									<settlement>Corvallis</settlement>
									<region>OR</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Russell</forename><forename type="middle">T</forename><surname>Turner</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">School of Biological and Population Health Sciences</orgName>
								<orgName type="laboratory">Skeletal Biology Laboratory</orgName>
								<orgName type="institution">Oregon State University</orgName>
								<address>
									<postCode>97331</postCode>
									<settlement>Corvallis</settlement>
									<region>OR</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Center for Healthy Aging Research</orgName>
								<orgName type="laboratory">Skeletal Biology Laboratory</orgName>
								<orgName type="institution">Oregon State University</orgName>
								<address>
									<postCode>97331</postCode>
									<settlement>Corvallis</settlement>
									<region>OR</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><roleName>Ph.D</roleName><forename type="first">Urszula</forename><forename type="middle">T</forename><surname>Iwaniec</surname></persName>
							<email>urszula.iwaniec@oregonstate.edu</email>
							<affiliation key="aff0">
								<orgName type="department">School of Biological and Population Health Sciences</orgName>
								<orgName type="laboratory">Skeletal Biology Laboratory</orgName>
								<orgName type="institution">Oregon State University</orgName>
								<address>
									<postCode>97331</postCode>
									<settlement>Corvallis</settlement>
									<region>OR</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Center for Healthy Aging Research</orgName>
								<orgName type="laboratory">Skeletal Biology Laboratory</orgName>
								<orgName type="institution">Oregon State University</orgName>
								<address>
									<postCode>97331</postCode>
									<settlement>Corvallis</settlement>
									<region>OR</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="department">School of Biological and Population Health Sciences</orgName>
								<orgName type="institution">Oregon State University</orgName>
								<address>
									<postCode>97331</postCode>
									<settlement>Corvallis</settlement>
									<region>OR</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Effects of hypothalamic leptin gene therapy on osteopetrosis in leptin-deficient mice</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Journal of Endocrinology</title>
						<idno type="ISSN">0022-0795</idno>
						<idno type="eISSN">1479-6805</idno>
						<imprint>
							<publisher>Bioscientifica</publisher>
							<biblScope unit="volume">236</biblScope>
							<biblScope unit="issue">2</biblScope>
							<biblScope unit="page" from="57" to="68"/>
							<date type="published" when="2019-02-01">2019 February 01.</date>
						</imprint>
					</monogr>
					<idno type="MD5">D65F3E68D40D3CBA33FD5AF6B0FE1372</idno>
					<idno type="DOI">10.1530/joe-17-0524</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-10-04T11:28+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=0, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=false, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], sentenceSegmentation=false, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>bone formation and resorption</term>
					<term>cartilage</term>
					<term>histology</term>
					<term>ob/ob</term>
					<term>osteoclast</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Impaired resorption of cartilage matrix deposited during endochondral ossification is a defining feature of juvenile osteopetrosis. Growing, leptin-deficient ob/ob mice exhibit a mild form of osteopetrosis. However, the extent to which the disease is (1) self-limiting and (2) reversible by leptin treatment is unknown. We addressed the first question by performing histomorphometric analysis of femurs in rapidly growing (2-month-old), slowly growing (4-month-old), and skeletally mature (6-month-old) wild type (WT) and ob/ob male mice. Absent by 6 months of age in WT mice, cartilage matrix persisted to varying extents in distal femur epiphysis, metaphysis and diaphysis in ob/ob mice, suggesting that the osteopetrotic phenotype is not entirely self-limiting.</p><p>To address the second question, we employed hypothalamic recombinant adeno-associated virus (rAAV) gene therapy to restore leptin signaling in ob/ob mice. Two-month-old mice were randomized to one of three groups: (1) untreated control, (2) rAAV-Leptin, or (3) control vector rAAV-green fluorescent protein and vectors injected intracerebroventricularly. Seven months later, rAAV-Leptin-treated mice exhibited no cartilage in the metaphysis and greatly reduced cartilage in the epiphysis and diaphysis. At the cellular level, the reduction in cartilage was associated with increased bone turnover. These findings (1) support the concept that leptin is important for normal replacement of cartilage by bone, and (2) demonstrate that osteopetrosis in ob/ob mice is bone compartment specific and reversible by leptin at skeletal sites capable of undergoing robust bone turnover.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>The appetite regulatory hormone leptin is produced by adipose tissue <ref type="bibr" target="#b53">(Zhang, et al. 1994)</ref>, circulates in levels proportional to total adiposity <ref type="bibr" target="#b9">(Considine, et al. 1996)</ref>, and may act to couple skeletal metabolism to energy availability <ref type="bibr" target="#b14">(Gat-Yablonski, et al. 2004;</ref><ref type="bibr" target="#b16">Hamrick 2004;</ref><ref type="bibr" target="#b22">Iwaniec, et al. 2007;</ref><ref type="bibr" target="#b40">Steppan, et al. 2000;</ref><ref type="bibr" target="#b42">Turner, et al. 2013;</ref><ref type="bibr" target="#b44">Turner, et al. 2014)</ref>. Long bones in leptin-deficient ob/ob mice are shorter, biomechanically weaker, and exhibit lower overall bone mass and greater marrow adiposity compared to wild type (WT) mice <ref type="bibr" target="#b13">(Ealey, et al. 2006;</ref><ref type="bibr" target="#b22">Iwaniec et al. 2007;</ref><ref type="bibr" target="#b31">Lindenmaier, et al. 2016;</ref><ref type="bibr" target="#b40">Steppan et al. 2000;</ref><ref type="bibr" target="#b44">Turner et al. 2014)</ref>. However, differences in cancellous bone volume fraction between ob/ob and WT mice vary depending upon skeletal site and age. Leptin treatment in leptin-deficient mice normalizes bone volume and microarchitecture <ref type="bibr" target="#b22">(Iwaniec et al. 2007</ref>) by increasing bone formation <ref type="bibr" target="#b1">(Bartell, et al. 2011;</ref><ref type="bibr" target="#b17">Hamrick, et al. 2005;</ref><ref type="bibr">Kalra, et al. 2009;</ref><ref type="bibr" target="#b40">Steppan et al. 2000;</ref><ref type="bibr" target="#b42">Turner et al. 2013</ref>) and resorption <ref type="bibr" target="#b1">(Bartell et al. 2011;</ref><ref type="bibr" target="#b36">Philbrick, et al. 2015;</ref><ref type="bibr" target="#b42">Turner et al. 2013;</ref><ref type="bibr" target="#b44">Turner et al. 2014)</ref>, and increasing longitudinal bone growth <ref type="bibr" target="#b14">(Gat-Yablonski et al. 2004;</ref><ref type="bibr" target="#b22">Iwaniec et al. 2007;</ref><ref type="bibr" target="#b36">Philbrick et al. 2015;</ref><ref type="bibr" target="#b42">Turner et al. 2013)</ref>. Leptin treatment also normalizes bone marrow adiposity by reducing marrow adipocyte number and size <ref type="bibr" target="#b31">(Lindenmaier et al. 2016)</ref>. Taken together, these findings indicate that leptin affects bone marrow adiposity and skeletal growth, maturation, and turnover balance.</p><p>Calcified cartilage provides a structural template for growing long bones during endochondral ossification and is normally replaced by bone during skeletal maturation. However, long bones of leptin-deficient ob/ob mice retain cartilage within cortical and cancellous bone compartments into adulthood resulting in a mild osteopetrotic skeletal phenotype <ref type="bibr" target="#b42">(Turner et al. 2013;</ref><ref type="bibr" target="#b44">Turner et al. 2014)</ref>. Osteopetrosis is broadly characterized into two major subtypes, osteoclast-poor and osteoclast-rich <ref type="bibr" target="#b39">(Sobacchi, et al. 2013</ref>). Mutations and/or factors that inhibit osteoclast formation are responsible for osteoclast-poor osteopetrosis. In contrast, mutations or factors that reduce osteoclast activity but do not inhibit osteoclast formation are responsible for the osteoclast-rich form of the disease. Both forms of osteopetrosis result in reduced bone resorption <ref type="bibr" target="#b0">(Arruda, et al. 2016;</ref><ref type="bibr" target="#b48">Unnanuntana, et al. 2011)</ref>. Severe osteopetrosis is fatal while mild forms, such as that noted in ob/ob mice, result in decreased bone quality. Furthermore, some forms of osteopetrosis are self-limiting; abnormally high quantities of cartilage are initially present in bone during rapid growth but the cartilage is eventually replaced as skeletal growth slows with age <ref type="bibr" target="#b8">(Cielinski and Marks 1994)</ref>. At present, it is unclear whether the mild osteopetrosis observed in growing ob/ob mice is self-limiting.</p><p>Osteoclast perimeter in ob/ob mice is equal to or greater than in WT mice <ref type="bibr">(Hamrick, et al. 2004;</ref><ref type="bibr" target="#b36">Philbrick et al. 2015;</ref><ref type="bibr" target="#b42">Turner et al. 2013;</ref><ref type="bibr" target="#b44">Turner et al. 2014)</ref>. In contrast, serum levels of carboxy-terminal collagen crosslinks (CTx, a biochemical marker of global bone resorption) are generally much lower and fluorochrome label retention in bone (a histomorphometric index of local bone resorption) is higher in ob/ob mice compared to WT mice, providing strong complementary evidence that leptin deficiency results in reduced bone resorption <ref type="bibr" target="#b1">(Bartell et al. 2011;</ref><ref type="bibr" target="#b42">Turner et al. 2013;</ref><ref type="bibr" target="#b44">Turner et al. 2014)</ref>. Theoretically, excessive bone formation could contribute to mild osteopetrosis. However, bone formation is impaired by leptin deficiency <ref type="bibr" target="#b1">(Bartell et al. 2011;</ref><ref type="bibr" target="#b17">Hamrick et al. 2005;</ref><ref type="bibr">Philbrick, et al. 2017;</ref><ref type="bibr" target="#b42">Turner et al. 2013;</ref><ref type="bibr" target="#b44">Turner et al. 2014)</ref>, indicating that lower osteoclastic activity is responsible for the condition in ob/ob mice.</p><p>Osteoclast-rich forms of osteopetrosis can be induced by loss of function mutations in genes coding for proteins such as protease cathepsin K or chloride transporter ClCN7 required for osteoclastic activity but not for osteoclast formation and survival <ref type="bibr" target="#b10">(Del Fattore, et al. 2008)</ref>. Additionally, drugs that inhibit bone resorption, such as bisphosphonates, have been shown to induce osteoclast-rich osteopetrosis in children <ref type="bibr" target="#b50">(Whyte, et al. 2003)</ref>. The mechanism for leptin regulation of osteoclast activity has yet to be established but likely involves coordinated actions of the hormone on multiple genes that in concert regulate osteoclast activity. In support, gene profiling has established that leptin deficiency results in altered expression of several genes related to osteoclast differentiation and function <ref type="bibr" target="#b44">(Turner et al. 2014</ref>).</p><p>In the present investigation, we queried the extent to which osteopetrosis in ob/ob mice is (1) self-limiting and (2) reversible by leptin treatment. We addressed the first question by performing histomorphometric analysis of femurs in rapidly growing (2-month-old), slowly growing (4-month-old), and skeletally mature (6-month-old) WT and ob/ob male mice. To address the second question, we employed hypothalamic recombinant adeno-associated virus (rAAV) gene therapy in 2-month-old ob/ob mice to restore leptin signaling and evaluated the bone response 7 months later. rAAV gene therapy has been used as an experimental strategy for life-long restoration of leptin signaling in leptin-deficient ob/ob mice <ref type="bibr" target="#b22">(Iwaniec et al. 2007;</ref><ref type="bibr">Iwaniec, et al. 2009;</ref><ref type="bibr" target="#b25">Kalra et al. 2009)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Animals</head><p>Male C57BL/6J (B6) mice and ob/ob mice on a B6 genetic background were obtained from Jackson Laboratory (Bar Harbor, Maine). Mice were maintained in accordance with the NIH Guide for the Care and Use of Laboratory Animals and the experimental protocols were approved by the Institutional Animal Care and Use Committee. Mice were housed individually in a temperature (22°C) and light-controlled (lights on 6am -6pm) room. Food (standard mouse chow) and water were available ad libitum to all animals.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study 1: Effects of Age and Leptin Status on Bone and Cartilage in Femur</head><p>Study 1 was performed in WT and ob/ob mice to determine the distribution of cartilage in femurs in animals sacrificed at 2 (n=10/group), 4 (n=5/group), and 6 (n=3-5/group) months of age. Two-month-old mice are rapidly growing while skeletal maturity is reached between 4 and 6 months of age.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study 2: Effect of Hypothalamic Leptin Gene Therapy on Bone and Cartilage in ob/ob Mice</head><p>Study 2 was performed in ob/ob mice to determine if the osteopetrotic skeletal phenotype persists in aged mice and, if so, whether long-duration hypothalamic leptin gene therapy normalizes skeletal maturation. Two-month-old ob/ob mice were randomized into one of three treatment groups: (1) untreated control (n=7), (2) rAAV-Leptin (rAAV-Lep, n=9), or rAAV-GFP (control vector encoding green fluorescent protein, n=7). The mice were maintained for 7 months post-vector administration. The effects of treatment on hypothalamic leptin gene expression, food intake, body weight, circulating metabolic hormone levels, bone microarchitecture, and bone marrow adiposity have been reported elsewhere <ref type="bibr">(Boghossian, et al. 2007;</ref><ref type="bibr" target="#b22">Iwaniec et al. 2007;</ref><ref type="bibr" target="#b31">Lindenmaier et al. 2016)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Construction and packaging of recombinant adenovirus vectors (rAAV)-</head><p>rAAV-Lep and rAAV-GFP vectors were constructed and packaged as described <ref type="bibr" target="#b5">(Beretta, et al. 2002)</ref>. In brief, the vector pTR-CBA-Ob EcoRI fragment of pCR-rOb containing rat leptin cDNA was subcloned into rAAV vector plasmid pAAVβGEnh after deleting the EcoRI fragment carrying the β-glucoronidase cDNA sequence. The control vector, rAAV-GFP, was similarly constructed to encode the GFP gene.</p><p>Vector administration-For vector administration, the mice were anesthetized with sodium pentobarbital (60 mg/kg, ip), placed on a Kopf stereotaxic apparatus with mouse adapter for intracerebroventricular (icv) injection, and injected icv with either rAAV-Lep (9 × 10 7 particles) or rAAV-GFP (9 × 10 7 particles). This dose was shown to normalize body weight in ob/ob mice <ref type="bibr" target="#b46">(Ueno, et al. 2004;</ref><ref type="bibr" target="#b47">Ueno, et al. 2006)</ref>. The coordinates employed for microinjector placement in the 3rd cerebroventricle were 0.3 mm posterior to bregma, 0.0 lateral to midline, and 4.2 mm below the dura <ref type="bibr" target="#b6">(Boghossian, et al. 2006)</ref>.</p><p>Tissue collection and analyses-Mice were anesthetized with either isoflurane delivered in oxygen (Study 1) or sodium pentobarbital (60 mg/kg; ip) (Study 2) and killed by exsanguination. Femora were excised, cleaned of soft tissue, placed in 10% formalin for 24 hrs, and stored in 70% ethanol until processing. Distal femora were prepared for histomorphometric evaluation as described <ref type="bibr" target="#b24">(Iwaniec, et al. 2008)</ref>. In brief, undecalcified femora were dehydrated and embedded in modified methyl methacrylate. Frontal sections, 4 μm thick, were cut with a vertical bed microtome (Leica 2065) and affixed to gel-coated slides. One slide was stained for tartrate resistant acid phosphatase and counter stained with toluidine blue (pH 2.5) to identify osteoclasts and cartilage matrix, respectively. Cartilage matrix was identified by metachromatic staining of proteoglycans and glycosaminoglycans. A second slide was stained using the Von Kossa method and counter stained with tetrachrome to identify osteoblasts and verify that linear growth had ceased in the femur in 6-month-old mice: the presence of bone bridging across the growth plate was used as an index of termination of longitudinal bone growth <ref type="bibr" target="#b33">(Martin, et al. 2003)</ref>. Cartilage was measured in cancellous bone in the distal femur epiphysis and metaphysis and in cortical bone in the femoral diaphysis. The entire cancellous envelope was evaluated in the distal femur epiphysis. The region of interest in the distal femur metaphysis was located 0.25-0.85 mm proximal to the growth plate and 0.05 mm from cortical bone. Cortical bone was evaluated 4.4-5.6 mm proximal to the growth plate. Measurements of cartilage included metachromatic stained area and chondrocyte area in the epiphysis, metaphysis, and diaphysis. Measurements excluded growth plate and articular cartilage matrix. Osteoclast perimeter (osteoclast perimeter/bone perimeter, %) and osteoblast perimeter (osteoblast perimeter/bone perimeter, %) were also determined in the epiphysis. Measurements were done at either 20 or 40x using the Osteomeasure Histomorphometry System (Osteometrics, Atlanta, GA). Histomorphometric data are reported using standard 2-dimensional nomenclature <ref type="bibr" target="#b11">(Dempster, et al. 2013)</ref>.</p><p>Statistics-Mean responses for bone and cartilage area fraction were compared between WT and ob/ob mice at ages 2 months, 4 months, and 6 months using analysis of covariance (age modeled as a quantitative variable with linear structure) or two-way analysis of variance (age modeled as a categorical variable). Goodness of fit assessment from scatterplots, Levene's test for homogeneity of variance, plots of residuals versus fitted values, normal quantile plots, and Anderson-Darling tests of normality, and model selection from Akaike's information criterion, Bayesian information criterion, and likelihood ratio tests were used to determine a linear model and evaluate contributions from interactions and main effects. Linear models containing different variance parameters across age and/or genotype groups were used to accommodate heterogeneous variance.</p><p>Mean responses for bone and cartilage fraction, and osteoblast and osteoclast perimeter were compared between the ob/ob, ob/ob + rAAV-GFP, and ob/ob + rAAV-Lep groups using oneway analysis of variance, with t-tests used to make pairwise comparisons. The Kruskal-Wallis nonparametric test was used when only the normality assumption was violated, in which case the Wilcoxon-Mann-Whitney test was used for two-group comparisons. A modified F test was used when variances were distinct, with Welch's two-sample t-test used for two-group comparisons <ref type="bibr" target="#b49">(Welch 1951)</ref>.</p><p>The Benjamini and Hochberg <ref type="bibr" target="#b4">(Benjamini and Hochberg 1995)</ref> method for maintaining the false discovery rate at 5% was used to adjust for multiple comparisons. Differences were considered significant at p ≤ 0.05. Trends are reported when P &lt; 0.1. All data are presented as mean ± SE. Data analysis was performed using R version 3.2.2.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study 1: Effects of Age and Leptin Status on Bone and Cartilage in Femur</head><p>The effects of age and leptin status on cancellous bone area fraction in the femoral epiphysis and metaphysis and on cartilage retention in the femoral epiphysis, metaphysis, and diaphysis in WT and ob/ob mice are shown in Figure <ref type="figure">1</ref>. Cancellous bone area fraction decreased with age in epiphysis (Figure <ref type="figure">1A</ref>) and metaphysis (Figure <ref type="figure">1C</ref>). The rate of decrease was not affected by genotype (interaction not significant). However, cancellous bone area fraction was lower in the epiphysis and tended to be lower (P &lt; 0.1) in the metaphysis in ob/ob mice compared to WT mice. Cartilage area fraction also decreased with age in the femoral epiphysis (Figure <ref type="figure">1B</ref>) and metaphysis (Figure <ref type="figure">1D</ref>), irrespective of genotype. Cartilage area fraction was higher in ob/ob compared to WT mice at both sites.</p><p>Negligible levels of cartilage matrix were observed in the diaphysis of WT mice (Figure <ref type="figure">1E</ref>). In contrast, cartilage matrix was present in the diaphysis of ob/ob mice and significant changes with age were not detected.</p><p>Photomicrographs illustrating the distribution of cartilage matrix in the femoral epiphysis, metaphysis, and diaphysis in representative 4-month-old WT and ob/ob mice are shown in Figure <ref type="figure">2</ref>. By 4 months of age, little cartilage remained in femur epiphysis, metaphysis, or diaphysis in WT mice. In contrast, cartilage is clearly evident at all 3 sites in ob/ob mice.</p><p>Bone bridging across the growth plate, indicative of cessation of longitudinal growth, was evident in 6-month-old WT and ob/ob mice (Figure <ref type="figure" target="#fig_2">3</ref>) but not in 2-month-old or 4-monthold mice, verifying cessation of linear growth by 6 months of age in both genotypes.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study 2: Effect of Hypothalamic Leptin Gene Therapy on Bone and Cartilage in ob/ob Mice</head><p>The effects of long-duration hypothalamic leptin gene therapy on cancellous bone area fraction in the femoral epiphysis and metaphysis and cartilage retention in the femoral epiphysis, metaphysis, and diaphysis in ob/ob mice are shown in Figure <ref type="figure" target="#fig_3">4</ref>. There was a tendency (P &lt; 0.1) for cancellous bone area fraction to be higher in the epiphysis of rAAV-Lep-treated mice compared to untreated and rAAV-GFP-treated control mice (Figure <ref type="figure" target="#fig_3">4A</ref>). Differences in cancellous bone area fraction were not detected with treatment in the femoral metaphysis (Figure <ref type="figure" target="#fig_3">4C</ref>). Cartilage matrix was present in the epiphysis (Figure <ref type="figure" target="#fig_3">4B</ref>), metaphysis (Figure <ref type="figure" target="#fig_3">4D</ref>), and diaphysis (Figure <ref type="figure" target="#fig_3">4E</ref>) in untreated and rAAV-GFP-treated control mice. Treatment with rAAV-Lep resulted in lower cartilage area fraction in the epiphysis, metaphysis, and diaphysis in comparison to untreated mice, lower cartilage area fraction in the metaphysis in comparison to rAAV-GFP mice and a tendency (P &lt; 0.1) for lower cartilage area fraction in the epiphysis and diaphysis in comparison to rAAV-GFP mice. Significant differences between untreated and rAAV-GFP-treated mice were not detected for any of the endpoints evaluated. Photomicrographs illustrating the distribution of cartilage matrix in representative 9-month-old untreated, rAAV-GFP-treated, and rAAV-Leptreated ob/ob mice are shown in Figure <ref type="figure" target="#fig_4">5</ref>.</p><p>The effects of long-duration hypothalamic leptin gene therapy on cellular indices of cancellous bone turnover in the femoral epiphysis are shown in Figure <ref type="figure">6</ref>. Osteoclast perimeter (Figure <ref type="figure">6A</ref>) and osteoblast perimeter (Figure <ref type="figure">6B</ref>) were higher in rAAV-Leptreated mice compared to untreated and rAAV-GFP-treated mice. Significant differences in either osteoclast perimeter or osteoblast perimeter were not detected between untreated and rAAV-GFP-treated controls.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>Compared to WT mice, more extracellular cartilage matrix was present in cancellous compartments (metaphysis and epiphysis) of distal femur in ob/ob mice. Cartilage matrix decreased with increasing age in both WT and ob/ob mice but, in marked contrast to WT mice, cartilage continued to be present in the epiphysis and metaphysis in skeletally mature 6-month-old ob/ob mice. Minimal or no cartilage matrix was found in the diaphysis of WT mice. In contrast, cartilage matrix was present in the diaphysis in ob/ob mice, but unlike at cancellous sites, did not decrease with age. Long-duration hypothalamic leptin gene therapy in growing ob/ob mice reduced cartilage matrix at all skeletal sites evaluated. Lack of differences between rAAV-Lep and rAAV-GFP-treated mice provides strong evidence that increased leptin levels and not differences arising from the application of gene therapy were responsible for the skeletal changes observed. At the cellular level, the reduction in cartilage in the epiphysis in rAAV-Lep-treated ob/ob mice was associated with increased bone turnover (increased osteoblast and osteoclast perimeters).</p><p>Bone resorption is reduced in leptin-deficient ob/ob mice and leptin receptor-deficient db/db mice due to impaired osteoclast function <ref type="bibr" target="#b42">(Turner et al. 2013;</ref><ref type="bibr" target="#b44">Turner et al. 2014)</ref>. Bone formation is also reduced in leptin-signaling-deficient mice due to reduced osteoblast-lined bone perimeter and reduced osteoblast activity <ref type="bibr" target="#b42">(Turner et al. 2013)</ref>. We hypothesized that the resulting reduction in turnover of primary spongiosa was the primary cause for prolonged retention of cartilage within the skeleton in ob/ob mice <ref type="bibr" target="#b42">(Turner et al. 2013;</ref><ref type="bibr" target="#b44">Turner et al. 2014)</ref>. This hypothesis is supported by the current study. The slower matrix turnover in the epiphysis compared to metaphysis was positively associated with longer retention of cartilage matrix. In addition, a reduction in cartilage in the epiphysis following hypothalamic leptin gene therapy was associated with increased bone turnover. A similar relationship was previously observed for the metaphysis <ref type="bibr" target="#b42">(Turner et al. 2013)</ref>.</p><p>Osteoclasts play a key role in endochondral ossification. Osteoclasts are essential for (1) generation of primary spongiosa by directing vascular invasion into the growth plate and (2) replacement of mineralized cartilage matrix by bone to form secondary spongiosa <ref type="bibr" target="#b34">(Odgren, et al. 2016)</ref>. Cartilage matrix is prevalent in distal femur in 2-month-old WT mice because the rate of cartilage matrix deposition during longitudinal growth exceeds the capacity of matrix turnover to replace cartilage with bone. However, longitudinal bone growth slows with age and in male B6 mice ceases between 4 and 6 months of age <ref type="bibr" target="#b15">(Glatt, et al. 2007;</ref><ref type="bibr" target="#b20">Hoshi, et al. 2004</ref>). Cessation of linear bone growth in small rodents is due to the formation of bony bridges across growth plate cartilage precluding further elongation <ref type="bibr" target="#b33">(Martin, et al. 2003</ref>). In the current study, bony bridges were observed in the distal femur growth plate at 6 months of age in WT as well as ob/ob mice. The age range for longitudinal growth cessation corresponds to the disappearance of cartilage matrix from cancellous compartments.</p><p>Endochondral ossification is disrupted in long bones of ob/ob mice, resulting in shorter bones, abnormal cancellous architecture, and delayed replacement of cartilage matrix in primary spongiosa by bone matrix <ref type="bibr" target="#b42">(Turner et al. 2013</ref>). In concordance with Kishida et al. <ref type="bibr" target="#b26">(Kishida, et al. 2005)</ref>, we noted disorganized growth plate architecture in the leptin-deficient mice. Furthermore, prior studies demonstrated that thinning of the proliferative zone of the growth plate is associated with reduced longitudinal bone growth rate <ref type="bibr" target="#b36">(Philbrick et al. 2015)</ref>. Chondrocytes express the leptin receptor <ref type="bibr" target="#b26">(Kishida et al. 2005;</ref><ref type="bibr" target="#b40">Steppan et al. 2000)</ref> and leptin was shown to exert positive actions affecting growth plate organization and growth plate expansion <ref type="bibr" target="#b14">(Gat-Yablonski et al. 2004;</ref><ref type="bibr" target="#b26">Kishida et al. 2005)</ref>. Hypertrophic chondrocytes contribute to programed removal of cartilage matrix by secretion of factors such as TNFSF11 (RANKL), MMP9 (matrix metallopeptidase 9), MMP13 (collagenase 3), and HMGB1 (high-mobility group protein 1) that mediate vascular invasion and are altered by leptin status <ref type="bibr" target="#b29">(Koskinen, et al. 2011;</ref><ref type="bibr" target="#b32">Mackie, et al. 2011;</ref><ref type="bibr" target="#b38">Schroeter, et al. 2012;</ref><ref type="bibr" target="#b52">Xiong, et al. 2011)</ref>. Thus, impaired chondrocyte function may contribute to the defect in osteoclast activity in ob/ob mice.</p><p>Cortical bone in the femoral diaphysis develops by secondary intramembranous ossification. The presence of cartilage within the diaphysis of ob/ob mice represents a pathological condition likely contributing to the lower biomechanical strength reported in ob/ob and db/db mice <ref type="bibr" target="#b13">(Ealey et al. 2006;</ref><ref type="bibr" target="#b19">Henriksen, et al. 2011;</ref><ref type="bibr" target="#b45">Tuukkanen, et al. 2000;</ref><ref type="bibr" target="#b51">Williams, et al. 2011)</ref>. Haversian (intracortical) bone remodeling is absent in mice. This may explain why cartilage matrix trapped in the distal femur diaphysis in ob/ob mice did not decline in quantity as the mice aged.</p><p>Leptin deficiency results in hypogonadism, hyperphagia, insulin resistance, and morbid obesity. These metabolic and endocrine abnormalities could indirectly influence bone metabolism and thus contribute to skeletal defects observed in ob/ob mice <ref type="bibr">(Turner, et al. 2017)</ref>. Indeed, normalization of food intake, weight gain, and blood glucose levels in ob/ob mice actually exaggerated the abnormal skeletal phenotype <ref type="bibr" target="#b44">(Turner et al. 2014)</ref>, while estrogen receptor blockade did not impair the skeletal response of ob/ob mice to leptin <ref type="bibr" target="#b43">(Turner et al. 2017)</ref>. Additionally, leptin exerted actions on the skeleton at levels having minimal impact on either energy metabolism or gonadal function <ref type="bibr" target="#b37">(Philbrick et al. 2017)</ref>. Taken together, these findings provide strong evidence that leptin acts on the skeleton to regulate bone growth and turnover.</p><p>Leptin deficiency also results in hypocalcemia <ref type="bibr" target="#b21">(Ishida, et al. 1988;</ref><ref type="bibr" target="#b35">Ozata, et al. 1999)</ref>, retinopathy <ref type="bibr" target="#b28">(Kondo and Kahn 2004)</ref>, hearing loss <ref type="bibr" target="#b30">(Lee, et al. 2008)</ref>, and tooth defects <ref type="bibr" target="#b2">(Batt 1978</ref><ref type="bibr" target="#b3">(Batt , 1992))</ref>. These abnormalities may be due, at least in part, to reduced osteoclast function. In support, defective bone resorption associated with osteopetrosis was shown to lead to impaired tooth eruption, and impaired hearing and vision <ref type="bibr" target="#b27">(Kocher and Kasser 2003)</ref>.</p><p>Hypothalamic leptin gene therapy normalized bone microarchitecture in growing ob/ob mice by increasing bone growth and turnover <ref type="bibr" target="#b22">(Iwaniec et al. 2007;</ref><ref type="bibr" target="#b25">Kalra et al. 2009;</ref><ref type="bibr" target="#b42">Turner et al. 2013</ref>). In the current study, hypothalamic leptin gene therapy promoted maturation of cancellous bone in distal femur. Infusion of leptin into the hypothalamus was initially reported to be antiosteogenic <ref type="bibr" target="#b12">(Ducy, et al. 2000)</ref> but subsequent studies failed to confirm this finding <ref type="bibr" target="#b1">(Bartell et al. 2011;</ref><ref type="bibr" target="#b17">Hamrick et al. 2005</ref>). Specifically, the latter studies reported that leptin infusion into the hypothalamus of ob/ob mice increased bone formation, bone mineral density, and expression of osteogenic genes <ref type="bibr" target="#b1">(Bartell et al. 2011;</ref><ref type="bibr" target="#b17">Hamrick et al. 2005)</ref>. In support, we observed that increasing hypothalamic leptin levels by gene therapy increased histomorphometric, biochemical, and gene expression markers of bone formation in ob/ob mice <ref type="bibr">(Turner, et al. 2015)</ref>. In addition to increased bone formation, hypothalamic leptin gene therapy increased osteoclast perimeter, an index of bone resorption, suggesting that leptin regulates bone turnover as well as bone accrual.</p><p>In summary, whereas cartilage matrix was absent within bone in 6-month-old WT mice, ob/ob mice retained cartilage matrix to varying degrees at all anatomical sites evaluated. Long-duration hypothalamic rAAV-Lep gene therapy in ob/ob mice increased bone turnover, resulting in substantial reduction in cartilage matrix within bone. Our findings (1) support the concept that leptin is important for normal replacement of cartilage by bone, and (2) demonstrate that osteopetrosis in ob/ob mice is site-specific and reversible by leptin at skeletal sites capable of undergoing robust bone turnover. Effects of age and genotype on cancellous bone area fraction in distal femur epiphysis (A) and metaphysis (C) and cartilage retention in cancellous bone in distal femur epiphysis (B) and metaphysis (D) and in cortical bone in femur diaphysis (E) in 2-month-old, 4-monthold, and 6-month-old male WT and leptin-deficient ob/ob mice. Data are mean ± SE; n = 10/ group for 2-month-old mice, n = 5/group for 4-month-old mice, n = 3 and 5/group for 6month-old WT and ob/ob mice, respectively. Photomicrographs of the distal femur epiphysis, metaphysis, and diaphysis in representative 4-month-old male WT mice (A, C, E) and 4-month-old male leptin-deficient ob/ob mice (B, D, F). Whereas cartilage matrix was rare in the epiphysis in WT mice (A), cartilage matrix and chondrocytes were readily visible in the epiphysis of ob/ob mice (B). Leptin-deficient ob/ob mice also exhibited a highly disorganized growth plate architecture, characterized by irregular margins and width (B). Cartilage was rare in the metaphysis and diaphysis of WT mice (C and E, respectively), but present at both sites in ob/ob mice (D and F).    Effects of long-duration (7 months) hypothalamic leptin gene therapy on osteoclast perimeter (A) and osteoblast perimeter (B) in distal femur epiphysis in male ob/ob mice.</p><p>Data are mean ± SE; n = 7-9/group. a different from untreated, P &lt; 0.05; b different from rAAV-GFP, P &lt; 0.05.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><figDesc>Figure 1.</figDesc><graphic coords="12,103.92,62.00,464.16,504.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><figDesc>Figure 2.</figDesc><graphic coords="13,159.60,62.00,352.80,504.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3 .</head><label>3</label><figDesc>Figure 3.Photomicrographs of growth plate in distal femur in representative 6-month-old male WT (A) and 6-month-old male leptin-deficient ob/ob mouse (B). The bony bridges are indicative of cessation of longitudinal growth.</figDesc><graphic coords="14,101.64,62.00,468.72,163.28" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 4 .</head><label>4</label><figDesc>Figure 4. Effects of long-duration (7 months) hypothalamic leptin gene therapy (rAAV-Lep) on cancellous bone area fraction in distal femur epiphysis (A) and metaphysis (C) and cartilage retention in cancellous bone in distal femur epiphysis (B) and metaphysis (D) and in cortical bone in femur diaphysis (E) in male ob/ob mice. Data are mean ± SE; n = 7-9/ group, a different from untreated, P &lt; 0.05, a *P &lt; 0.1; b different rAAV-GFP, P &lt; 0.05, b *P &lt; 0.1.</figDesc><graphic coords="15,101.76,62.00,468.48,475.20" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 5 .</head><label>5</label><figDesc>Figure 5. Photomicrographs of the distal femur epiphysis (A, B, C), metaphysis (D, E, F), and diaphysis (G, H, I) in representative 9-month-old untreated, rAAV-GFP-treated and rAAV-Lep-treated male ob/ob mice at 7 months post-vector administration. Note the presence of cartilage matrix in epiphysis, metaphysis, and diaphysis of untreated mice (A, D, and G, respectively) and rAAV-GFP-treated mice (B, E, and H, respectively) and its absence in rAAV-Lep-treated mice (C, F, and I, respectively).</figDesc><graphic coords="16,159.24,62.00,353.52,503.66" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><figDesc>Figure 6.</figDesc><graphic coords="17,180.48,62.00,311.04,155.52" type="bitmap" /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p>J Endocrinol. Author manuscript; available in PMC 2019 February 01.</p></note>
		</body>
		<back>

			<div type="acknowledgement">
<div><head>Acknowledgments</head><p>We thank <rs type="person">Dr. S.P. Kalra</rs> for designing study 2 and for providing the bone specimens for analysis from this study and <rs type="person">Dr. S. Boghossian</rs> for executing study 2. Philbrick et al.  </p></div>
			</div>
			<div type="funding">
<div><p>Funding: This work was supported by grants from the <rs type="funder">NIH</rs> (<rs type="grantNumber">AR 054609</rs>), <rs type="funder">NASA</rs> (<rs type="grantNumber">NNX12AL24</rs>), and <rs type="funder">USDA</rs> (<rs type="grantNumber">38420-17804</rs>).</p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_KCugWpY">
					<idno type="grant-number">AR 054609</idno>
				</org>
				<org type="funding" xml:id="_b9MJhhw">
					<idno type="grant-number">NNX12AL24</idno>
				</org>
				<org type="funding" xml:id="_2q4SAre">
					<idno type="grant-number">38420-17804</idno>
				</org>
			</listOrg>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Bone Mineral Density and Microarchitecture in Patients With Autosomal Dominant Osteopetrosis: A Report of Two Cases</title>
		<author>
			<persName><forename type="first">M</forename><surname>Arruda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Coelho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Moraes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Paula</forename><surname>De</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Paranhos-Neto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Madeira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Farias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Vieira</forename><surname>Neto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename></persName>
		</author>
		<idno type="PMID">26387875</idno>
	</analytic>
	<monogr>
		<title level="j">J Bone Miner Res</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="657" to="662" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Central (ICV) leptin injection increases bone formation, bone mineral density, muscle mass, serum IGF-1, and the expression of osteogenic genes in leptin-deficient ob/ob mice</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Bartell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rayalam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ambati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Gaddam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Hartzell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hamrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">X</forename><surname>She</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Della-Fera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Baile</surname></persName>
		</author>
		<idno type="PMID">21520275</idno>
	</analytic>
	<monogr>
		<title level="j">J Bone Miner Res</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="1710" to="1720" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Abnormal dentition and decrease in body weight in the genetically obese mouse (genotype, ob/ob)</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Batt</surname></persName>
		</author>
		<idno type="PMID">744683</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Obes</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="457" to="462" />
			<date type="published" when="1978">1978</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Abnormal incisor teeth and body weight in the obese mouse (genotype ob/ob)</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Batt</surname></persName>
		</author>
		<idno type="PMID">1314241</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Obes Relat Metab Disord</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="29" to="34" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Controlling the false discovery rate: a practical and powerful approach to multiple testing</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Benjamini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hochberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Royal Statistical Society Series B</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="289" to="300" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Long-term suppression of weight gain, adiposity, and serum insulin by central leptin gene therapy in prepubertal rats: effects on serum ghrelin and appetiteregulating genes</title>
		<author>
			<persName><forename type="first">E</forename><surname>Beretta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Dube</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Kalra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Kalra</surname></persName>
		</author>
		<idno type="PMID">12149495</idno>
	</analytic>
	<monogr>
		<title level="j">Pediatr Res</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="189" to="198" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Hypothalamic clamp on insulin release by leptin-transgene expression</title>
		<author>
			<persName><forename type="first">S</forename><surname>Boghossian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Dube</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Torto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Kalra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Kalra</surname></persName>
		</author>
		<idno type="PMID">16962683</idno>
	</analytic>
	<monogr>
		<title level="j">Peptides</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="3245" to="3254" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Leptin gene transfer in the hypothalamus enhances longevity in adult monogenic mutant mice in the absence of circulating leptin</title>
		<author>
			<persName><forename type="first">S</forename><surname>Boghossian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ueno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Dube</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kalra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kalra</surname></persName>
		</author>
		<idno type="PMID">17011078</idno>
	</analytic>
	<monogr>
		<title level="j">Neurobiol Aging</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="1594" to="1604" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Neonatal reductions in osteoclast number and function account for the transient nature of osteopetrosis in the rat mutation microphthalmia blanc (mib)</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Cielinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Marks</surname><genName>Jr</genName></persName>
		</author>
		<idno type="PMID">7873301</idno>
	</analytic>
	<monogr>
		<title level="j">Bone</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="707" to="715" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Serum immunoreactive-leptin concentrations in normalweight and obese humans</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">V</forename><surname>Considine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Sinha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Heiman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kriauciunas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">W</forename><surname>Stephens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Nyce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Ohannesian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Marco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Mckee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Bauer</surname></persName>
		</author>
		<idno type="PMID">8532024</idno>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">334</biblScope>
			<biblScope unit="page" from="292" to="295" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Genetics, pathogenesis and complications of osteopetrosis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Del Fattore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cappariello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Teti</surname></persName>
		</author>
		<idno type="PMID">17936098</idno>
	</analytic>
	<monogr>
		<title level="j">Bone</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="19" to="29" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Dempster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Compston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Drezner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">H</forename><surname>Glorieux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Kanis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Malluche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Meunier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Ott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Recker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Parfitt</surname></persName>
		</author>
		<idno type="PMID">23197339</idno>
	</analytic>
	<monogr>
		<title level="j">J Bone Miner Res</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="2" to="17" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass</title>
		<author>
			<persName><forename type="first">P</forename><surname>Ducy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Amling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Takeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Priemel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Schilling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">T</forename><surname>Beil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Vinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Rueger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Karsenty</surname></persName>
		</author>
		<idno type="PMID">10660043</idno>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="197" to="207" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Bone abnormalities in adolescent leptin-deficient mice</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">N</forename><surname>Ealey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fonseca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Archer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Ward</surname></persName>
		</author>
		<idno type="PMID">16764953</idno>
	</analytic>
	<monogr>
		<title level="j">Regul Pept</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="page" from="9" to="13" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Leptin reverses the inhibitory effect of caloric restriction on longitudinal growth</title>
		<author>
			<persName><forename type="first">G</forename><surname>Gat-Yablonski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ben-Ari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Shtaif</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Potievsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Moran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Eshet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Maor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Segev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Phillip</surname></persName>
		</author>
		<idno type="PMID">14525912</idno>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">145</biblScope>
			<biblScope unit="page" from="343" to="350" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Age-related changes in trabecular architecture differ in female and male C57BL/6J mice</title>
		<author>
			<persName><forename type="first">V</forename><surname>Glatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Canalis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Stadmeyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Bouxsein</surname></persName>
		</author>
		<idno type="PMID">17488199</idno>
	</analytic>
	<monogr>
		<title level="j">J Bone Miner Res</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="1197" to="1207" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Leptin, bone mass, and the thrifty phenotype</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Hamrick</surname></persName>
		</author>
		<idno type="PMID">15355554</idno>
	</analytic>
	<monogr>
		<title level="j">J Bone Miner Res</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="1607" to="1611" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Hamrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Della-Fera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pennington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hartzell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Baile</surname></persName>
		</author>
		<idno type="PMID">15883640</idno>
	</analytic>
	<monogr>
		<title level="j">J Bone Miner Res</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="994" to="1001" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Leptin deficiency produces contrasting phenotypes in bones of the limb and spine</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Hamrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pennington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Newton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Isales</surname></persName>
		</author>
		<idno type="PMID">15003785</idno>
	</analytic>
	<monogr>
		<title level="j">Bone</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="376" to="383" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Dissociation of bone resorption and bone formation in adult mice with a non-functional V-ATPase in osteoclasts leads to increased bone strength</title>
		<author>
			<persName><forename type="first">K</forename><surname>Henriksen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Flores</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Thomsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Bruel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Thudium</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Neutzsky-Wulff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Langenbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sims</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Askmyr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Martin</surname></persName>
		</author>
		<idno type="PMID">22087326</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">27482</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Deficiency of insulin receptor substrate-1 impairs skeletal growth through early closure of epiphyseal cartilage</title>
		<author>
			<persName><forename type="first">K</forename><surname>Hoshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ogata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Shimoaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Terauchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kadowaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kenmotsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">I</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ozawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nakamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kawaguchi</surname></persName>
		</author>
		<idno type="PMID">14969391</idno>
	</analytic>
	<monogr>
		<title level="j">J Bone Miner Res</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="214" to="223" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">The number of 1,25-dihydroxyvitamin D3 receptors is decreased in both intestine and kidney of genetically diabetic db/db mice</title>
		<author>
			<persName><forename type="first">H</forename><surname>Ishida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Cunningham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Henry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Norman</surname></persName>
		</author>
		<idno type="PMID">2836163</idno>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="page" from="2436" to="2443" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Central leptin gene therapy corrects skeletal abnormalities in leptin-deficient ob/ob mice</title>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">T</forename><surname>Iwaniec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Boghossian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Lapke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Kalra</surname></persName>
		</author>
		<idno type="PMID">17346852</idno>
	</analytic>
	<monogr>
		<title level="j">Peptides</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="1012" to="1019" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Body mass influences cortical bone mass independent of leptin signaling</title>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">T</forename><surname>Iwaniec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Dube</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Boghossian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Helferich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Kalra</surname></persName>
		</author>
		<idno type="PMID">19095090</idno>
	</analytic>
	<monogr>
		<title level="j">Bone</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="404" to="412" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Histological analysis of bone</title>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">T</forename><surname>Iwaniec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Wronski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Turner</surname></persName>
		</author>
		<idno type="PMID">18369927</idno>
	</analytic>
	<monogr>
		<title level="j">Methods Mol Biol</title>
		<imprint>
			<biblScope unit="volume">447</biblScope>
			<biblScope unit="page" from="325" to="341" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Leptin increases osteoblast-specific osteocalcin release through a hypothalamic relay</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Kalra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Dube</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">T</forename><surname>Iwaniec</surname></persName>
		</author>
		<idno type="PMID">19428775</idno>
	</analytic>
	<monogr>
		<title level="j">Peptides</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="967" to="973" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Leptin regulates chondrocyte differentiation and matrix maturation during endochondral ossification</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Kishida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hirao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Tamai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nampei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fujimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Nakase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Shimizu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yoshikawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Myoui</surname></persName>
		</author>
		<idno type="PMID">16039170</idno>
	</analytic>
	<monogr>
		<title level="j">Bone</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="607" to="621" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Osteopetrosis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Kocher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Kasser</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Orthop</title>
		<imprint>
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Altered insulin signaling in retinal tissue in diabetic states</title>
		<author>
			<persName><forename type="first">T</forename><surname>Kondo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Kahn</surname></persName>
		</author>
		<idno type="PMID">15201286</idno>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">279</biblScope>
			<biblScope unit="page" from="37997" to="38006" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Leptin enhances MMP-1, MMP-3 and MMP-13 production in human osteoarthritic cartilage and correlates with MMP-1 and MMP-3 in synovial fluid from OA patients</title>
		<author>
			<persName><forename type="first">A</forename><surname>Koskinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Vuolteenaho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Nieminen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Moilanen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Moilanen</surname></persName>
		</author>
		<idno type="PMID">21345293</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Rheumatol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="57" to="64" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Early sensorineural hearing loss in ob/ob mouse, an animal model of type 2 diabetes</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">S</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Hong</surname></persName>
		</author>
		<idno type="PMID">19434270</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Otorhinolaryngol</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="211" to="216" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Hypothalamic leptin gene therapy reduces bone marrow adiposity in ob/ob mice fed regular and high-fat diets</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Lindenmaier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Philbrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Branscum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Kalra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">T</forename><surname>Iwaniec</surname></persName>
		</author>
		<idno type="PMID">27579023</idno>
	</analytic>
	<monogr>
		<title level="j">Front Endocrinol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">110</biblScope>
			<date type="published" when="2016">2016</date>
			<pubPlace>Lausanne</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">The skeleton: a multi-functional complex organ: the growth plate chondrocyte and endochondral ossification</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Mackie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tatarczuch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mirams</surname></persName>
		</author>
		<idno type="PMID">21642379</idno>
	</analytic>
	<monogr>
		<title level="j">J Endocrinol</title>
		<imprint>
			<biblScope unit="volume">211</biblScope>
			<biblScope unit="page" from="109" to="121" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Time course of epiphyseal growth plate fusion in rat tibiae</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Ritman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Turner</surname></persName>
		</author>
		<idno type="PMID">12667553</idno>
	</analytic>
	<monogr>
		<title level="j">Bone</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="261" to="267" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">The cast of clasts: catabolism and vascular invasion during bone growth, repair, and disease by osteoclasts, chondroclasts, and septoclasts</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Odgren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Witwicka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Reyes</forename><forename type="middle">-</forename><surname>Gutierrez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename></persName>
		</author>
		<idno type="PMID">26818783</idno>
	</analytic>
	<monogr>
		<title level="j">Connect Tissue Res</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="161" to="174" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ozata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">C</forename><surname>Ozdemir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Licinio</surname></persName>
		</author>
		<idno type="PMID">10523015</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="3686" to="3695" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Paradoxical effects of partial leptin deficiency on bone in growing female mice</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Philbrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Branscum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">T</forename><surname>Iwaniec</surname></persName>
		</author>
		<idno type="PMID">26370912</idno>
	</analytic>
	<monogr>
		<title level="j">Anat Rec</title>
		<imprint>
			<biblScope unit="volume">298</biblScope>
			<biblScope unit="page" from="2018" to="2029" />
			<date type="published" when="2015">2015</date>
			<pubPlace>Hoboken)</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Leptin stimulates bone formation in ob/ob mice at doses having minimal impact on energy metabolism</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Philbrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Branscum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">T</forename><surname>Iwaniec</surname></persName>
		</author>
		<idno type="PMID">28057869</idno>
	</analytic>
	<monogr>
		<title level="j">J Endocrinol</title>
		<imprint>
			<biblScope unit="volume">232</biblScope>
			<biblScope unit="page" from="461" to="474" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Leptin promotes the mobilization of vascular progenitor cells and neovascularization by NOX2-mediated activation of MMP9</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Schroeter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Stein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Heida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Leifheit-Nestler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">F</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gogiraju</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Christiansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Maier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Hasenfuss</surname></persName>
		</author>
		<idno type="PMID">22065732</idno>
	</analytic>
	<monogr>
		<title level="j">Cardiovasc Res</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="170" to="180" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Osteopetrosis: genetics, treatment and new insights into osteoclast function</title>
		<author>
			<persName><forename type="first">C</forename><surname>Sobacchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schulz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">P</forename><surname>Coxon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Villa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Helfrich</surname></persName>
		</author>
		<idno type="PMID">23877423</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Endocrinol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="522" to="536" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Leptin is a potent stimulator of bone growth in ob/ob mice</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Steppan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T</forename><surname>Crawford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Chidsey-Frink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Swick</surname></persName>
		</author>
		<idno type="PMID">11024568</idno>
	</analytic>
	<monogr>
		<title level="j">Regul Pept</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="73" to="78" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Hypothalamic leptin gene therapy reduces body weight without accelerating agerelated bone loss</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dube</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Branscum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Olson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Kweh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">V</forename><surname>Larkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Wronski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Rosen</surname></persName>
		</author>
		<idno type="PMID">26487675</idno>
	</analytic>
	<monogr>
		<title level="j">J Endocrinol</title>
		<imprint>
			<biblScope unit="volume">227</biblScope>
			<biblScope unit="page" from="129" to="141" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Peripheral leptin regulates bone formation</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Kalra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Philbrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Lindenmaier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Boghossian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">T</forename><surname>Iwaniec</surname></persName>
		</author>
		<idno type="PMID">22887758</idno>
	</analytic>
	<monogr>
		<title level="j">J Bone Miner Res</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="22" to="34" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Role of estrogen receptor signaling in skeletal response to leptin in female ob/ob mice</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Philbrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Kuah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Branscum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">T</forename><surname>Iwaniec</surname></persName>
		</author>
		<idno type="PMID">28428364</idno>
	</analytic>
	<monogr>
		<title level="j">J Endocrinol</title>
		<imprint>
			<biblScope unit="volume">233</biblScope>
			<biblScope unit="page" from="357" to="367" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Morbid obesity attenuates the skeletal abnormalities associated with leptin deficiency in mice</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Philbrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Olson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Branscum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">T</forename><surname>Iwaniec</surname></persName>
		</author>
		<idno type="PMID">24990938</idno>
	</analytic>
	<monogr>
		<title level="j">J Endocrinol</title>
		<imprint>
			<biblScope unit="volume">223</biblScope>
			<biblScope unit="page" from="1" to="15" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Mineral density and bone strength are dissociated in long bones of rat osteopetrotic mutations</title>
		<author>
			<persName><forename type="first">J</forename><surname>Tuukkanen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Koivukangas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Jamsa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sundquist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Mackay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Marks</surname><genName>Jr</genName></persName>
		</author>
		<idno type="PMID">11028442</idno>
	</analytic>
	<monogr>
		<title level="j">J Bone Miner Res</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="1905" to="1911" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Leptin modulates orexigenic effects of ghrelin and attenuates adiponectin and insulin levels and selectively the dark-phase feeding as revealed by central leptin gene therapy</title>
		<author>
			<persName><forename type="first">N</forename><surname>Ueno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Dube</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Inui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Kalra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Kalra</surname></persName>
		</author>
		<idno type="PMID">15155574</idno>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">145</biblScope>
			<biblScope unit="page" from="4176" to="4184" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Leptin transgene expression in the hypothalamus enforces euglycemia in diabetic, insulin-deficient nonobese Akita mice and leptin-deficient obese ob/ob mice</title>
		<author>
			<persName><forename type="first">N</forename><surname>Ueno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Inui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Kalra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Kalra</surname></persName>
		</author>
		<idno type="PMID">16621153</idno>
	</analytic>
	<monogr>
		<title level="j">Peptides</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="2332" to="2342" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Diseases affecting bone quality: beyond osteoporosis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Unnanuntana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Rebolledo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Khair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Dicarlo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Lane</surname></persName>
		</author>
		<idno type="PMID">21107923</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Orthop Relat Res</title>
		<imprint>
			<biblScope unit="volume">469</biblScope>
			<biblScope unit="page" from="2194" to="2206" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">On the comparison of several mean values: an alternative approach</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Welch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biometrika</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="330" to="336" />
			<date type="published" when="1951">1951</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Bisphosphonate-induced osteopetrosis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Whyte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wenkert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Clements</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Mcalister</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mumm</surname></persName>
		</author>
		<idno type="PMID">12890844</idno>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">349</biblScope>
			<biblScope unit="page" from="457" to="463" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Skeletal phenotype of the leptin receptor-deficient db/db mouse</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Callon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Watson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Costa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dickinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Naot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">R</forename><surname>Reid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cornish</surname></persName>
		</author>
		<idno type="PMID">21328476</idno>
	</analytic>
	<monogr>
		<title level="j">J Bone Miner Res</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="1698" to="1709" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Matrix-embedded cells control osteoclast formation</title>
		<author>
			<persName><forename type="first">J</forename><surname>Xiong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Onal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Jilka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Weinstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Manolagas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Brien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename></persName>
		</author>
		<idno type="PMID">21909103</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="1235" to="1241" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Positional cloning of the mouse obese gene and its human homologue</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Proenca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Maffei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Barone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Leopold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Friedman</surname></persName>
		</author>
		<idno type="PMID">7984236</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">372</biblScope>
			<biblScope unit="page" from="425" to="432" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
